607 related articles for article (PubMed ID: 23040596)
1. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
[TBL] [Abstract][Full Text] [Related]
2. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
[TBL] [Abstract][Full Text] [Related]
3. Burden of atrial fibrillation and poor rate control detected by continuous monitoring and the risk for heart failure hospitalization.
Sarkar S; Koehler J; Crossley GH; Tang WH; Abraham WT; Warman EN; Whellan DJ
Am Heart J; 2012 Oct; 164(4):616-24. PubMed ID: 23067922
[TBL] [Abstract][Full Text] [Related]
4. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
5. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
6. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
[TBL] [Abstract][Full Text] [Related]
7. Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.
Gillis AM; Kerr CR; Philippon F; Newton G; Talajic M; Froeschl M; Froeschl S; Swiggum E; Yetisir E; Wells GA; Tang AS
Circulation; 2014 May; 129(20):2021-30. PubMed ID: 24610807
[TBL] [Abstract][Full Text] [Related]
8. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
[TBL] [Abstract][Full Text] [Related]
9. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
[TBL] [Abstract][Full Text] [Related]
10. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury (AKI) and risk of readmissions in patients with heart failure.
Thakar CV; Parikh PJ; Liu Y
Am J Cardiol; 2012 May; 109(10):1482-6. PubMed ID: 22381163
[TBL] [Abstract][Full Text] [Related]
12. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial.
Starling RC; Krum H; Bril S; Tsintzos SI; Rogers T; Hudnall JH; Martin DO
JACC Heart Fail; 2015 Jul; 3(7):565-572. PubMed ID: 26071616
[TBL] [Abstract][Full Text] [Related]
13. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
[TBL] [Abstract][Full Text] [Related]
14. The European CRT Survey: 1 year (9-15 months) follow-up results.
Bogale N; Priori S; Cleland JG; Brugada J; Linde C; Auricchio A; van Veldhuisen DJ; Limbourg T; Gitt A; Gras D; Stellbrink C; Gasparini M; Metra M; Derumeaux G; Gadler F; Buga L; Dickstein K;
Eur J Heart Fail; 2012 Jan; 14(1):61-73. PubMed ID: 22179034
[TBL] [Abstract][Full Text] [Related]
15. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
[TBL] [Abstract][Full Text] [Related]
16. Cardiac resynchronization therapy reduces the risk of cardiac events in patients with diabetes enrolled in the multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy (MADIT-CRT).
Martin DT; McNitt S; Nesto RW; Rutter MK; Moss AJ
Circ Heart Fail; 2011 May; 4(3):332-8. PubMed ID: 21350054
[TBL] [Abstract][Full Text] [Related]
17. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
[TBL] [Abstract][Full Text] [Related]
18. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
[TBL] [Abstract][Full Text] [Related]
19. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
[TBL] [Abstract][Full Text] [Related]
20. Device diagnostics and long-term clinical outcome in patients receiving cardiac resynchronization therapy.
Singh JP; Rosenthal LS; Hranitzky PM; Berg KC; Mullin CM; Thackeray L; Kaplan A
Europace; 2009 Dec; 11(12):1647-53. PubMed ID: 19752011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
